SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) January 9, 2003
MERCK & CO., Inc.
New Jersey
1-3305 | 22-1109110 | |
|
||
(Commission File Number) |
(I.R.S. Employer Identification No.) |
One Merck Drive, PO Box 100, Whitehouse Station, NJ 08889-0100 |
(Address of Principal Executive Offices) (Zip Code) |
Registrants telephone number, including area code (908)423-1000
Item 5. Other Events | ||||||||
Item 7. Financial Statements and Exhibits | ||||||||
SIGNATURES | ||||||||
EXHIBIT INDEX | ||||||||
PRESS RELEASE |
Item 5. Other Events
Incorporated by reference is a press release issued by the Registrant on January 9, 2003, attached as Exhibit 99, regarding the Registrants announcement that it plans to launch a tender offer to purchase the remaining 49 percent of the common shares of Banyu Pharmaceutical Co., Ltd. that it does not already own.
Item 7. Financial Statements and Exhibits
(c) | Exhibits |
Exhibit 99 |
Press release issued January 9, 2003 |
Filed with this document |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
MERCK & CO., INC. | ||||
Date: January 10, 2003 | By: | /s/ Debra A. Bollwage |
||
DEBRA A. BOLLWAGE Assistant Secretary |
EXHIBIT INDEX
Exhibit | ||
Number | Description | |
99 | Press release issued January 9, 2003 |